Fortress Biotech, Inc. (NASDAQ:FBIOP) Plans $0.20 Monthly Dividend

Fortress Biotech, Inc. (NASDAQ:FBIOP) announced a monthly dividend on Thursday, May 9th, Wall Street Journal reports. Stockholders of record on Wednesday, May 15th will be paid a dividend of 0.1953 per share on Friday, May 31st. This represents a $2.34 annualized dividend and a dividend yield of 14.23%. The ex-dividend date is Tuesday, May 14th.

Fortress Biotech Trading Up 1.6 %

FBIOP traded up $0.26 during trading on Thursday, hitting $16.47. 3,381 shares of the stock were exchanged, compared to its average volume of 12,539. Fortress Biotech has a 1-year low of $6.40 and a 1-year high of $18.91. The stock has a fifty day moving average price of $15.96 and a two-hundred day moving average price of $13.79.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet.